ADVERTISEMENT
Dr Reddy's Labs Commences Clinical Trials Of Sputnik V Vaccine; Stock Gains 1%
02 Dec 2020, 11:22 AM IST 
Save
The Sputnik V vaccine developed by Gamaleya National Research Institute of Epidemiology and Microbiology
Dr Reddy's Labs has commenced clinical trials of Sputnik V vaccine in India in collaboration with Russian Direct Investment Fund (RDIF). In September 2020, Dr. Reddy's and RDIF had entered into a partnership to conduct clinical trials of the Sputnik V vaccine and the rights for distribution of the first 100 million doses in India.
